mobinitinib   Click here for help

GtoPdb Ligand ID: 13496

Synonyms: CCT-241736 | CCT241736
Compound class: Synthetic organic
Comment: The chemical structure for mobinitinib was obtained from WHO proposed INN list 131 (August 2024). This is a structural match to the dual fms-like tyrosine kinase 3 (FLT3)/Aurora kinase inhibitor CCT241736 [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 58.83
Molecular weight 456.37
XLogP 2.44
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NN(C)C=C1C2=NC3=NC=C(C(=C3N2)N4CCN(CC4)CC5=CC=C(C=C5)Cl)Cl
Isomeric SMILES CC1=NN(C=C1C2=NC3=NC=C(C(=C3N2)N4CCN(CC4)CC5=CC=C(C=C5)Cl)Cl)C
InChI InChI=1S/C22H23Cl2N7/c1-14-17(13-29(2)28-14)21-26-19-20(18(24)11-25-22(19)27-21)31-9-7-30(8-10-31)12-15-3-5-16(23)6-4-15/h3-6,11,13H,7-10,12H2,1-2H3,(H,25,26,27)
InChI Key AKJBLKUZXRMECW-UHFFFAOYSA-N
References
1. Moore AS, Faisal A, Mak GWY, Miraki-Moud F, Bavetsias V, Valenti M, Box G, Hallsworth A, de Haven Brandon A, Xavier CPR et al.. (2020)
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736.
Blood Adv, 4 (7): 1478-1491. [PMID:32282883]
2. Wood FL, Shepherd S, Hayes A, Liu M, Grira K, Mok Y, Atrash B, Faisal A, Bavetsias V, Linardopoulos S et al.. (2019)
Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species.
Eur J Pharm Sci, 139: 104899. [PMID:30953752]